Less invasive ablation may rival surgery for liver tumors

NCT ID NCT07559851

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at 151 patients with colorectal cancer that spread to the liver (tumors 5 cm or smaller). Researchers compared two treatments: ablation (using heat to destroy tumors) plus chemotherapy, versus surgery to remove the tumors plus chemotherapy. The goal was to see which approach led to longer time without the cancer growing. The study found that both treatments had similar outcomes, suggesting ablation could be a good alternative to surgery for some patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
microwave ablation
What this could lead to
If this study shows ablation is as effective as surgery, it could offer a less invasive option for patients with colorectal liver metastases.
What could go wrong
This is a retrospective study, not a randomized trial, so results may be biased. The findings need confirmation in larger, prospective studies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL LIVER METASTASIS (CRLM) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The First Hospital of Jilin University

    Changchun, Jilin, 130012, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.